
IDEX’s third quarter was marked by solid execution and strong organic growth, leading to a positive market reaction. Management highlighted that momentum in Health & Science Technologies (HST), along with robust demand from data centers, municipal water, and pharma, were key drivers this quarter. CEO Eric Ashleman credited the company’s “8020 philosophy” for enabling operational improvements and rapid integration of recent acquisitions, while noting that recent efforts in the Material Science Solutions platform and intelligent water businesses contributed meaningfully to performance.
Is now the time to buy IEX? Find out in our full research report (it’s free for active Edge members).
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
In upcoming quarters, our analysts will focus on (1) the pace of organic growth in HST and municipal water platforms, (2) management’s ability to sustain margin improvements through ongoing cost initiatives, and (3) signs of stabilization or acceleration in industrial demand across bellwether businesses. Progress on bolt-on acquisitions and the execution of platform integrations will also be key indicators of future performance.
IDEX currently trades at $167.96, in line with $166.95 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free for active Edge members).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Aug-21 | |
| Jul-29 | |
| Jul-29 | |
| Jul-29 | |
| Jul-29 | |
| Jul-29 | |
| Jul-20 | |
| Jul-06 | |
| Jun-29 | |
| Jun-17 | |
| May-06 | |
| Apr-29 | |
| Apr-29 | |
| Apr-29 | |
| Apr-17 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite